Detail akcie Haleon Rg online

Business Summary: Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Haleon PLC revenues decreased 4% to L5.48B. Net income increased 11% to L806M. Revenues reflect EMEA and LatAm segment decrease of 54% to L1.12B, North America segment decrease of 55% to L871M. Net income reflects Finance expense decrease of 9% to L176M (expense), Finance income increase of 52% to L47M (income). Dividend per share remained flat at L0.02.